Kazazian Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,569
| Closed | -$220K | – | 60 |
|
|
2019
Q2 | $220K | Sell |
2,569
-333
| -11% | -$28.5K | 0.26% | 54 |
|
|
2019
Q1 | $258K | Sell |
2,902
-1,000
| -26% | -$88.9K | 0.36% | 46 |
|
|
2018
Q4 | $332K | Sell |
3,902
-2,122
| -35% | -$181K | 0.45% | 41 |
|
|
2018
Q3 | $584K | Buy |
6,024
+2,890
| +92% | +$280K | 0.55% | 43 |
|
|
2018
Q2 | $295K | Sell |
3,134
-120
| -4% | -$11.3K | 0.27% | 71 |
|
|
2018
Q1 | $264K | Hold |
3,254
| – | – | 0.28% | 66 |
|
|
2017
Q4 | $290K | Buy |
+3,254
| New | +$290K | 0.3% | 66 |
|
|
2017
Q3 | – | Sell |
-3,424
| Closed | -$311K | – | 71 |
|
|
2017
Q2 | $311K | Buy |
+3,424
| New | +$311K | 0.47% | 39 |
|